- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Di | RenovoRx, Inc.: RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer | 337 | MOUNTAIN VIEW, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or "the Company") (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and... ► Artikel lesen | ||
| Di | The Marketing Alliance Announces Financial Results for First Quarter Ended June 30, 2026 | 214 | ST. LOUIS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The Marketing Alliance, Inc. (OTC: MAAL) ("TMA" or the "Company"), announced its financial results today for its fiscal 2027 first quarter ended June 30... ► Artikel lesen | ||
| Di | SurgePays, Inc.: SurgePays Reports 23% Month-Over-Month Growth in Smartphone Rent-to-Own Program, Reaching $176,000 in July Retail Sales | 195 | BARTLETT, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- SurgePays, Inc. (NASDAQ: SURG) ("SurgePays" or the "Company"), a wireless and fintech company connecting subprime and underserved consumers to essential... ► Artikel lesen | ||
| Di | Reborn Coffee, Inc.: Reborn Coffee Signs Strategic Memorandum of Understanding with The Mighty Oak Inc. to Expand U.S. Produce Sales Across H Mart, Hannam Chain and GW Supermarket | 151 | BREA, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Reborn Coffee Inc. (Nasdaq: REBN) (the "Company"), a leader in the specialty coffee market, announced today that it has entered into a Strategic Memorandum... ► Artikel lesen | ||
| Di | Idaho Copper Corporation: Idaho Copper Appoints Four Independent Directors and Establishes Board Committees | 544 | Gil Atzmon, David Herskovits, Dr. John Moeller and Corey Redfield Add Mining Development, Public Company Audit, Commodities Trading and Idaho Permitting Expertise to the Board BOISE, Idaho, Aug. 11... ► Artikel lesen | ||
| Di | Nocera, Inc: Nocera Clears Every Open Nasdaq Listing Matter With Stockholders' Equity of $5.4 Million - More Than Double the Required Minimum - and Turns Full Attention to Acquisitions | 599 | TAIPEI, Taiwan, Aug. 11, 2026 (GLOBE NEWSWIRE) -- via IBN - Nocera, Inc. (NASDAQ:NCRA) ("Nocera" or the "Company") today announced that it has received written notification from the Listing Qualifications... ► Artikel lesen | ||
| Di | Companhia Siderúrgica Nacional: Announcement of Final Results of Private Exchange Offer for CSN Inova Ventures' Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation | 243 | São Paulo, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Companhia Siderúrgica Nacional ("CSN") (NYSE: SID) announced today the final results of the offer to exchange (the "Exchange Offer") conducted by its subsidiary... ► Artikel lesen | ||
| Di | PDS Biotechnology Corporation: PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101 | 676 | PRINCETON, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy company focused on developing targeted... ► Artikel lesen | ||
| Di | Mereo BioPharma Group plc: Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights | 306 | Entered into option and license agreement with Sentynl Therapeutics for alvelestat, Mereo's investigational oral therapy for Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) Mereo... ► Artikel lesen | ||
| Di | Clearmind Medicine Inc.: Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting Enhanced Nasal Retention Without Compromising Drug Delivery | 535 | Vancouver, Canada, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND, FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and... ► Artikel lesen | ||
| Di | cBrain A/S: cBrain introduces a new approach to scaling government AI | 320 | PRESS RELEASE no. 04/2026 cBrain introduces a new approach to scaling government AI Copenhagen, August 11, 2026 cBrain® (NASDAQ: CBRAIN) today introduces F2 AI Case Preparation, a new AI technology... ► Artikel lesen | ||
| Di | Teva Pharmaceutical Industries Ltd: Moody's Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy | 726 | TEL AVIV, Israel, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Moody's Ratings has upgraded Teva's corporate credit rating to Baa3... ► Artikel lesen | ||
| Di | Nu-Tek Biosciences, LLC: Nu-Tek BioSciences Earns EcoVadis Bronze Rating for Third Consecutive Year, Strengthening Sustainable Biopharmaceutical Supplier Status | 247 | EcoVadis recognition reinforces Nu-Tek's sustained investment in the sustainable manufacturing of animal-origin-free cell culture media nutrients and fermentation ingredients.
MINNETONKA, Minn.... ► Artikel lesen | ||
| Di | SparkCharge Launches in the United Kingdom, Bringing AI-Optimized Energy Infrastructure to Autonomous Vehicle Fleet Operations Without the Wait | 341 | Building on its proven operations in the US, the leading mobile energy network is expanding its international footprint with new deployments that will deliver power to autonomous vehicle companies and... ► Artikel lesen | ||
| Di | Theriva Biologics, Inc.: Theriva Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results | 334 | - First patients dosed in the VIRAGE2 Phase 2a clinical study evaluating more frequent repeated dosing of VCN-01 (zabilugene almadenorepvec) the goal of which is to improve treatment outcomes in metastatic... ► Artikel lesen | ||
| Di | Canadian National Railway Company: CN Reports a Record 2025-26 Crop Year | 442 | MONTREAL, Aug. 11, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that it closed the 2025-26 crop year with a record movement of more than 33.8 million metric tonnes (MMT) of... ► Artikel lesen | ||
| Di | Mereo BioPharma Group plc: Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) | 304 | Sentynl expands its rare disease portfolio with potential first-in-class oral treatment for AATD-LD, a rare genetic respiratory diseaseOn option exercise, Sentynl will have the right to commercialize... ► Artikel lesen | ||
| Di | Abundia Global Impact Group, Inc.: Abundia Global Impact Group Provides Business Update Highlighting Continued Execution of Commercialization Strategy | 132 | Measurable progress, additional revenue stream and strong balance sheet represent disciplined and consistent execution of the company's business strategy HOUSTON, TX, Aug. 11, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | ||
| Di | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Announces IMCIVREE (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity ... | 300 | BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with... ► Artikel lesen | ||
| Di | Baiya International Group Inc. Announces Additional $2 Million Strategic Investment in BNB, Bringing Total Strategic Investment to $3 Million | 137 | Further Advancing the Binance Plan Through Long-Term Capital Allocation While Expanding the Company's Digital Asset Portfolio SHENZHEN, China, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Baiya International... ► Artikel lesen | ||
| Di | Big Sky Industrial Inc. Reports Second Quarter 2026 Results and Highlights Phase 1 Construction Progress at Big Sky Carbon Hub | 144 | Advances Phase 1 Processing Facility Construction and Gathering Infrastructure Toward Targeted First Revenue in the First Quarter of 2027 Five-Year, 100% Take-or-Pay Helium Offtake Provides Contracted... ► Artikel lesen | ||
| Di | Kalaris Therapeutics, Inc.: Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates | 207 | Patient dosing is ongoing in the Phase 1b/2 study of TH103; preliminary data anticipated in 1H 2027 Potential Phase 3 clinical trials remain on track for initiation by year-end 2027 $93.5 million... ► Artikel lesen | ||
| Di | LB Pharmaceuticals Inc: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update | 179 | Announced accelerated timing of topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027 Announced plans for pipeline expansion of LB-102 into... ► Artikel lesen | ||
| Di | Reflex Advanced Materials Corp.: Reflex Advanced Announces Strategic Review | 795 | NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp. (CSE:RFLX)... ► Artikel lesen | ||
| Di | TON Strategy Company Reports Second Quarter 2026 Financial Results | 189 | Generated $15.0 million of Gram staking revenue Held approximately 230.5 million Gram at June 30, including approximately 229.9 million Gram deployed in staking Executed primary actions expected... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.